Influence of skeletal muscle volume loss during lenvatinib treatment on prognosis in unresectable hepatocellular carcinoma: a multicenter study in Tohoku, Japan

Sarcopenia is associated with poor prognosis of patients with hepatocellular carcinoma (HCC). We investigated the association of skeletal muscle volume (SMV) and its change in HCC patients taking lenvatinib. In 130 HCC patients, psoas mass index (PMI) was calculated as the left–right sum of the majo...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, Masashi, Abe, Kazumichi, Kuroda, Hidekatsu, Oikawa, Takayoshi, Ninomiya, Masashi, Masamune, Atsushi, Okumoto, Kazuo, Katsumi, Tomohiro, Sato, Wataru, Iijima, Katsunori, Endo, Tetsu, Fukuda, Shinsaku, Tanabe, Nobukazu, Numao, Hiroshi, Takikawa, Yasuhiro, Ueno, Yoshiyuki, Ohira, Hiromasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021276/
https://www.ncbi.nlm.nih.gov/pubmed/35444161
http://dx.doi.org/10.1038/s41598-022-10514-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021276/
https://www.ncbi.nlm.nih.gov/pubmed/35444161
http://dx.doi.org/10.1038/s41598-022-10514-3

Ejemplares similares